MIR4435-2HG: A Newly Proposed LncRNA in Human Cancer
Overview
General Medicine
Pharmacology
Affiliations
Long non-coding RNAs (lncRNAs) play important roles in the occurrence and progression of tumors. Extensive research has contributed to the current understanding of the critical roles played by lncRNAs in various cancers. LncRNA MIR4435-2HG has been found to be crucial in many cancers, such as breast, cervical, colorectal, and gastric cancer. Expression of MIR4435-2HG is generally upregulated in cancers and MIR4435-2HG participates in many biological functions through molecular mechanism of competitive endogenous RNA networks. This review profiles recent research findings on the expression, functions, mechanism, and clinical value of MIR4435-2HG in cancer, and serves as a reference for further MIR4435-2HG-related research and clinical trials.
Xie B, Wu P, Liu H, Yang X, Huang L J Transl Med. 2025; 23(1):165.
PMID: 39920781 PMC: 11806857. DOI: 10.1186/s12967-025-06128-8.
Current insights and future directions of LncRNA Morrbid in disease pathogenesis.
Yang H, Gao J, Zheng Z, Yu Y, Zhang C Heliyon. 2024; 10(17):e36681.
PMID: 39263145 PMC: 11388785. DOI: 10.1016/j.heliyon.2024.e36681.
Chen Z, Du Y, Shi H, Dong S, He R, Zhou W Transl Cancer Res. 2024; 13(8):4113-4130.
PMID: 39262472 PMC: 11385540. DOI: 10.21037/tcr-24-51.
Yang X, Zhang Y, Liu J, Feng Y Medicine (Baltimore). 2024; 103(27):e38750.
PMID: 38968515 PMC: 11224815. DOI: 10.1097/MD.0000000000038750.
Liu R, Qian K, He X, Li H BMC Bioinformatics. 2024; 25(1):116.
PMID: 38493095 PMC: 10944609. DOI: 10.1186/s12859-024-05706-9.